Kodiak Sciences Set to Showcase Innovations at Key Investor Conferences in November and December 2025

Kodiak Sciences to Feature at Major Investor Conferences

PALO ALTO, Calif., Nov. 12, 2025 — Kodiak Sciences Inc. (Nasdaq: KOD), a pioneering biotechnology firm focusing on retinal therapies, has announced its participation in two significant investor conferences coming up this November and December. Notable for their influence in the healthcare investment community, these conferences will see Kodiak's CEO, Dr. Victor Perlroth, present insights into the company's innovative approaches and product developments.

Conference Details

The first conference will be held at the Jefferies Global Healthcare Conference in London, UK, on November 17, 2025, at 4:30 PM GMT (8:30 AM PST). Dr. Perlroth will deliver a comprehensive presentation showcasing the latest advancements in Kodiak's pipeline, highlighting their commitment to transforming retinal health outcomes.

The second event is the 8th Annual Evercore Healthcare Conference scheduled for December 3, 2025, in Coral Gables, Florida. This session will take place at 3:00 PM EST (12:00 PM PST) and will feature a casual fireside chat format. Here, Kodiak will delve deeper into its strategic vision and the potential impact of its therapies on patients facing vision loss.

Both presentations will be accessible through live webcasts on Kodiak's official website in the